Cytochrome P-4502E1: Its physiological and pathological role

Physiological Reviews

Volumn 77, Issue 2, 1997, Pages 517-544

  Lieber, Charles S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; CATALASE; CYTOCHROME P450; HYDROXYL RADICAL; KETONE; MICROSOME ENZYME;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ALCOHOL OXIDATION; ARTICLE; CARCINOGENESIS; DIABETES MELLITUS; ENERGY BALANCE; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME POLYMORPHISM; ENZYME PURIFICATION; GENE EXPRESSION REGULATION; KETOGENESIS; LIPID METABOLISM; LIVER INJURY; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; STARVATION;

EID: 0030935567     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1997.77.2.517     Document Type: Article

References (351)

1. ALBANO, E., A. TOMASI, L. GORIA-GATTI, AND M. U. DIANZANI. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem. Biol. Interact. 65: 223-234, 1988.
2. ALBANO, E., A. TOMASI, L. GORIA-GATTI, J. O. PERSSON, Y. TEREIUS, L. GORIA-GATTI, M. INGELMAN-SUNDBERG, AND M. U. DIANZANI. Role of ethanol-inducible cytochrome P450 (P450IIE1) in catalyzing the free radical activation of alphatic alcohols. Biochem. Pharmacol. 41: 1895-1902, 1991.
3. ALBANO, E., A. TOMASI, L. GORIA-GATTI, G. POLI, V. VANNINI, AND M. U. DIANZANI. Free radical metabolism of alcohol by rat liver microsomes. Free Radical Res. Commun. 3: 243-249, 1987.
4. ALBANO, E., A. TOMASI, AND M. INGELMAN-SUNDBERG. Spin trapping of alcohol derived radicals in microsomes and reconstituted systems by electron spin resonance. Methods Enzymol. 223: 117-127, 1994.
5. ALDERMAN, J., S. KATO, AND C. S. LIEBER. The microsomal ethanol oxidizing system mediates metabolic tolerance to ethanol in deermice lacking alcohol dehydrogenase. Arch. Biochem. Biophys. 27: 33-39, 1989.
6. ALDERMAN, J., T. TAKAGI, AND C. S. LIEBER. Ethanol metabolizing pathways in deermice: estimation of flux calculated from isotope effects. J. Biol. Chem. 262: 7497-7503, 1987.
7. AMET, Y., F. BERTHOU, T. GOASDUFF, J. P. SALAUN, L. LEBRETON, AND J. F. MENEZ. Evidence that cytochrome P450 2E1 is involved in the (ω-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem. Biophys. Res. Commun. 203: 1168-1174, 1994.
8. 3 content and changes in phospholipids. Biochim. Biophys. Acta 797: 320-327, 1984.
9. BADGER, T. M., J. HUANG, M. RONIS, AND C. K. LUMPKIN. Induction of cytochrome P450 2E1 during chronic ethanol exposure occurs via transcription of the CYP 2E1 gene when blood alcohol concentrations are high. Biochem. Biophys. Res Commun. 190: 780-785, 1993.
10. BARAONA, E., W. LIU, X. L. MA, G. SVEGLIATI-BARONI, AND C. S. LIEBER. Acetaldehyde-collagen adducts in N-nitrosodimethylamine-induced liver cirrhosis in rats. Life Sci. 52: 1249-1255, 1993.
11. BEHRENS, U. J., M. HOERNER, J. M. LASKER, AND C. S. LIEBER. Formation of acetaldehyde adducts with ethanol inducible P-450IIE1 in vivo. Biochem. Biophys. Res. Commun. 154: 584-590, 1988.
12. BELLWARD, G. D., T. CHANG, J. H. RODRIGUES, J. H. MCNEIL, S. MAINES, D. E. RYAN, W. LEVIN, AND P. E. THOMAS. Hepatic cytochrome P-450J induction in the spontaneously diabetic BB rat. Mol. Pharmacol. 33: 140-143, 1987.
13. BERTHOU, F., T. GOASDUFF, Y. DREANO, AND J. F. MENEZ. Caffeine metabolism by hepatic microsomes of rats treated by inducers of CYP1A and CYP2E1 (Abstract). Int. Symp. Microsomal Drug Oxidations 10th Toronto Canada 1994, p. 606.
14. BESKID, M., J. BIALCK, J. DZIENISZEWSKI, J. SADOWSKI, AND J. TLALKA. Effect of combined phenylbutazone and ethanol administration on rat liver. Exp. Pathol. 18: 487-491, 1980.
15. BESTERVELT, L. L., A. D. VAZ, AND M. J. COON. Inactivation of ethanol-inducible cytochrome P-450 and other microsomal P-450 isozymes by trans-4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation. Proc. Natl. Acad. Sci. USA 92: 3764-3768, 1995.
16. BOROWSKY, S. A., AND C. S. LIEBER. Interaction of methadone and ethanol metabolism. J. Pharmacol. Exp. Ther. 207: 123-129, 1978.
17. BOTTO, F., E. SEREE, S. E. KHYARI, G. DESOUSA, A. MASSACRIER, M. PLACIDI, P. CAU, W. PELLET, R. RAHMANI, AND Y. BARRA. Tissue specific expression and methylation of the human CYP2E1 gene. Biochem. Pharmacol. 48: 1095-1103, 1994.
18. BRADY, J. F., H. ISHIZAKI, J. M. FUKUTO, M. C. LIN, A. FADEL, J. M. GUPAC, AND C. S. YANG. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem. Res. Toxicol. 4: 642-647, 1991.
19. BRADY, J. F., M. J. LEE, M. LI, H. ISHIZAKI, AND C. S. YANG. Diethyl ether as a substrate for acetone/ethanol-inducible cytochrome P-450 and as an inducer for cytochrome(s) P-450. Mol. Pharmacol. 33: 148-154, 1987.
20. BRADY, J. F., D. LI, H. ISHIZAKI, AND C. S. YANG. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res. 48: 5937-5940, 1988.
21. BRADY, J. F., M. LI, H. ISHIZAKI, M. LEE, S. M. NING, F. XIAO, AND C. S. YANG. Induction of cytochromes P-450IIE1 and P-450IIB1 by secondary ketones and the role of P-450IIE1 in chloroform metabolism. Toxicol. Appl. Pharmacol. 100: 342-349, 1989.
22. BRADY, J. F., F. XIAO, S. M. NING, AND C. S. YANG. Metabolism of methyl tertiary butyl ether by rat liver microsomes. Arch. Toxicol. 64: 157-160, 1990.
23. BRADY, J. F., F. XIAO, M. H. WANG, Y. LI, S. M. NING, J. M. GAPAC, AND C. S. YANG. Effects of disulfiram on hepatic P-450IIE1, other microsomal enzymes, and hepatotoxicity in rats. Toxicol. Appl. Pharmacol. 108: 366-373, 1991.
24. BUCHLER, R., K. O. LINDROS, K. VON BOGUSLAWSKY, P. KARKKAINEN, J. MAKINEN, AND M. INGELMAN-SUNDBERG. Perivenous expression of ethanol-inducible cytochrome P-450IIE1 in livers from alcoholics and chronically ethanol-fed rats. Alcohol Alcohol. 1, Suppl.: 311-315, 1991.
25. BURNETT, K. G., AND M. R. FELDER. Ethanol metabolism in peromyscus genetically deficient in alcohol dehydrogenase. Biochem. Pharmacol. 28: 1-8, 1980.
26. CARR, L. G., J. Y. HARTLEROAD, Y. B. LIANG, C. MENDENHALL, T. MORITZ, AND H. THOMASSON. Polymorphism at the P-450IIE1 locus is not associated with alcoholic liver disease in Caucasian men. Alcohol Clin. Exp. Res. 19: 182-184, 1995.
27. CARRIERE, V., T. GOASDUFF, D. RATANASAVANH, F. MOREL, J.-C. GAUTIER, A. GUILLOUZO, P. BEAUNE, AND F. BERTHOU. Both cytochromes P-450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem. Res. Toxicol. 6: 852-857, 1993.
28. CARROCCIO, A., D. WU, AND A. I. CEDERBAUM. Ethanol increases content and activity of human cytochrome P-4502E1 in a transduced HepG2 cell line. Biochem. Biophys. Res. Commun. 203: 727-733, 1994.
29. CARTER, E. A., AND K. J. ISSELBACHER. The role of microsomes in the hepatic metabolism of ethanol. Ann. NY Acad. Sci. 179: 282-294, 1971.
30. CASAZZA, J. P., M. E. FELVER, AND R. L. VEECH. The metabolism of acetone in rat. J. Biol. Chem. 259: 231-236, 1984.
31. CASAZZA, J. P., AND J. L. FU. Measurement of acetol in serum. Anal. Biochem. 148: 344-348, 1985.
32. CASAZZA, J. P., AND R. L. VEECH. The production of 1,2 propanediol in ethanol treated rats. Biochem. Biophys. Res. Commun. 129: 426-430, 1985.
33. CEDERBAUM, A. I. Introduction: role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radical Biol. Med. 7: 537-539, 1989.
34. CEDERBAUM, A. I. Oxygen radical generation by microsomes: role of iron and implications for alcohol metabolism and toxicity. Free Radical Biol. Med. 7: 559-567, 1989.
35. CEDERBAUM, A. I., E. DICKER, E. RUBIN, AND G. COHEN. The effect of dimethylsulfoxide and other hydroxyl radical scavengers on the oxidation of ethanol by rat liver microsomes. Biochem. Biophys. Res. Commun. 78: 1254-1262, 1977.
36. CEDERBAUM, A. I., C. S. LIEBER, AND E. RUBIN. Effects of chronic ethanol treatment on mitochondrial functions. Arch. Biochem. Biophys. 165: 560-569, 1974.
37. CHANCE, B. An intermediate compound in the catalase-hydrogen reaction. Acta Chem. Scand. 1: 236-267, 1947.
38. CHEDID, A., AND V. NAIR. Diurnal rhythm in endoplasmic reticulum of rat liver: electron microscopic study. Science Wash. DC 175: 176-179, 1972.
39. CHEN, L., M. LEE, J.-Y. HONG, W. HUANG, E. WANG, AND C. S. YANG. Relationship between cytochrome P-450 2E1 and acetone catabolism in rats as studied with diallyl sulfide as an inhibitor. Biochem. Pharmacol. 48: 2199-2205, 1994.
40. CHIELI, E., M. SAVIOZZI, S. MENICAGLI, T. BRANCA, AND P. G. GERVASI. Hepatotoxicity and P-4502E1 dependent metabolic oxidation of N,N-dimethylformamide in rats and mice. Arch. Toxicol. 69: 165-170, 1995.
41. CHIELI, E., M. SAVIOZZI, P. PUCCINI, V. LONGO, AND P. G. GERVASI. Possible role of the acetone-inducible cytochrome P-450IIE1 in the metabolism and hepatotoxicity of thiobenzamide. Arch. Toxicol. 64: 122-127, 1990.
42. CLARK, S. E., S. J. BALDWIN, J. C. BLOOMER, A. D. AYRTON, R. S. SOZIO, AND R. J. CHENERY. Lauric acid as a model substrate for the simultaneous determination of cytochrome P-450 2E1 and 4A in hepatic microsomes. Chem. Res. Toxicol. 7: 836-842, 1994.
43. CLEJAN, L. A., AND A. I. CEDERBAUM. Oxidation of pyrazole by reconstituted systems containing cytochrome P-450 IIE1. Biochim. Biophys. Acta 1034: 233-237, 1990.
44. CLEJAN, L. A., AND A. I. CEDERBAUM. Role of cytochrome P-450 in the oxidation of glycerol by reconstituted systems and microsomes. FASEB J. 6: 765-770, 1992.
45. COMAI, K., AND J. L. GAYLOR. Existence and separation of three forms of cytochrome P-450 from rat liver microsomes. J. Biol. Chem. 248: 4947-4955, 1973.
46. CONNEY, A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19: 317-366, 1967.
47. DAI, Y., J. RASHBA-STEP, AND A. I. CEDERBAUM. Stable expression of human cytochrome P-4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 32: 6928-6937, 1993.
48. DEWAZIERS, I., M. GARLATTI, J. BOUGUET, P. H. BEAUNE, AND R. BAROUKI. Insulin down-regulates cytochrome P-450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line. Mol. Pharmacol. 47: 474-479, 1995.
49. DICKER, E., AND A. I. CEDERBAUM. Hydroxyl radical generation by microsomes after chronic ethanol consumption. Alcohol. Clin. Exp. Res. 11: 309-314, 1987.
50. DICKER, E., AND A. I. CEDERBAUM. Increased oxygen radical dependent inactivation of metabolic enzymes by liver microsomes after chronic ethanol consumption. FASEB J. 2: 2901-2906, 1988.
51. DIEHL, A. M., H. C. BISGAARD, B. T. KEEN, AND C. J. STEER. Ethanol interferes with regeneration-associated changes in biotransforming enzymes: a potential mechanism underlying ethanol's carcinogenicity? Hepatology 13: 722-727, 1991.
52. DILUZIO, N. R. Prevention of the acute ethanol induced fatty liver by the simultaneous administration of anti-oxidants. Life Sci. 3: 113-119, 1964.
53. DILUZIO, N. R. The role of lipid peroxidation and antioxidants in ethanol induced lipid alterations. Exp. Mol. Pathol. 8: 394-402, 1968.
54. DING, X., AND M. J. COON. Induction of cytochrome P-450 isozyme 3a (P-450IIE1) in rabbit olfactory mucosa by ethanol and acetone. Drug Metab. Dispos. 18: 742-745, 1988.
55. DING, X., D. R. KOOP, B. I. CRUMP, AND M. J. COON. Immunochemical identification of cytochrome P-450 isozyme 3a [P-450ALC] in rabbit nasal and kidney microsomes and evidence for differential induction by alcohol. Mol. Pharmacol. 30: 370-378, 1986.
56. DI PADOVA, C., T. M. WORNER, R. J. K. JULKUNEN, AND C. S. LIEBER. Effects of fasting and chronic alcohol consumption on the first pass metabolism of ethanol. Gastroenterology 92: 1169-1173, 1987.
57. DONG, Z., J. HONG, Q. MA, D. LI, J. BULLOCK, F. J. GONZALEZ, S. S. PARK, H. V. GELBOIN, AND C. S. YANG. Mechanism of Induction of Cytochrome P-450AC (P-450J) in Chemically Induced and Spontaneously Diabetic Rats. Orlando, FL: Academic, 1988, p. 29-35.
58. DOWSLEY, T. F., P. G. FORKERT, L. A. BENESCH, AND J. L. BOLTON. Reaction of glutathione with the electrophilic metabolites of 1,1-dichloroethylene. Chem. Biol. Interact. 95: 227-244, 1995.
59. DUESCHER, R. J., AND A. A. ELFARRA. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P-450 2D6 and 2E1. Arch. Biochem. Biophys. 311: 342-349, 1994.
60. EARNEST, D. L., E. R. ABRIL, C. S. JOLLEY, AND D. C. ESKELSON. Kupffer cell function is modified by both diet and ethanol. Adv. Biosci. 86: 181-190, 1993.
61. EKSTROM, G., AND M. INGELMAN-SUNDBERG. Rat liver microsomal NADPH supported oxide activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem. Pharmacol. 38: 1313-1319, 1989.
62. ELIASSON, E., I. JOHANSSON, AND M. INGELMAN-SUNDBERG. Ligand dependent maintenance of ethanol inducible cytochrome P-450 in primary rat hepatocyte cell cultures. Biochem. Biophys. Res. Commun. 150: 436-443, 1988.
63. ELIASSON, E., S. MKRTCHIAN, AND M. INGELMAN-SUNDBERG. Hormone- and substrate-regulated intracellular degradation of cytochrome P-450 (2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes. J. Biol. Chem. 267: 15765-15769, 1992.
64. 6-methylguanine transferase. Carcinogenesis 9: 761-766, 1988.
65. FABRY, T. L., AND C. S. LIEBER. The photochemical action spectrum of the microsomal ethanol oxidizing system. Alcohol. Clin. Exp. Res. 3: 219-222, 1979.
66. FARINATI, F., Z. ZHOU, J. BELLAH, C. S. LIEBER, AND A. J. GARRO. Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung and hepatic tissue. Drug Metab. Dispos. 13: 210-214, 1985.
67. FEIERMAN, D. E., AND A. I. CEDERBAUM. Role of cytochrome P-450 IIE1 and catalase in the oxidation of acetonitrile to cyanide. Chem. Res. Toxicol. 2: 359-366, 1989.
68. FEIERMAN, D. E., G. W. WINSTON, AND A. I. CEDERBAUM. Ethanol oxidation by hydroxyl radicals: role of iron chelates, superoxide and hydrogen peroxide. Alcohol. Clin. Exp. Res. 9: 95-102, 1985.
69. FEINMAN, L., E. BARAONA, S. MATSUZAKI, M. KORSTEN, AND C. S. LIEBER. Concentration dependence of ethanol metabolism in vivo in rats and man. Alcohol. Clin. Exp. Res. 2: 381-385, 1978.
70. FIALA, E. S. Inhibition of carcinogen metabolism and action by disulfiram, pyrazole, and related compounds. In: Inhibition of Tumor Induction and Development, edited by M. S. Zadeck and M. Lipkin. New York: Plenum, 1981, p. 23-69.
71. FRENCH, S. W., K. WONG, L. JUI, E. ALBANO, A. L. HAGBJORK, AND M. INGELMAN-SUNDBERG. Effect of ethanol on cytochrome P-450 2E1 (CYP2E1) lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp. Mol. Pathol. 58: 61-75, 1993.
72. FUJIMIYA, T., K. YAMAOKA, AND Y. FUKUI. Parallel first-order and Michaelis Menten elimination kinetics of ethanol: respective role of alcohol dehydrogenase (ADH), non-ADH and first order pathways. J. Pharmacol. Exp. Ther. 249: 311-317, 1989.
73. FUKUDA, T., Y. IMAI, M. KOMORI, M. NAKAMURA, E. KUSUNOSE, K. SATOOCHI, AND M. KUSUNOSE. Different mechanisms of regioselection of fatty acid hydroxylation by laurate (omega-1) hydroxylating P450s, P-450 2C2 and P-450 2E1. J. Biochem. Tokyo 115: 338-344, 1994.
74. GANNETT, P. M., P. IVERSEN, AND T. LAWSON. The mechanism of inhibition of cytochrome P-450IIE1 by dihydrocapsaicin. Bioorg. Chem. 18: 185-198, 1990.
75. GARRO, A. J., H. K. SEITZ, AND C. S. LIEBER. Enhancement of dimethylnitrosamine metabolism and activation to a mutagen following chronic ethanol consumption. Cancer Res. 41: 120-124, 1981.
76. GENG, J., AND H. W. STROBEL. Identification of cytochromes P-450 1A2, 2A1, 2C7, 2E1 in rat glioma C6 cell line by RT PCR and specific restriction enzyme digestion. Biochem. Biophys. Res. Commun. 197: 1179-1184, 1993.
77. CENTER, M. B., N. J. DEAMER, Y. CAO, AND P. E. LEVI. Effects of P-450 inhibition and induction on the olfactory toxicity of β-iminodipropionitrile (IDPN) in the rat. J. Biochem. Toxicol. 9: 31-39, 1994.
78. GEORGE, J., C. LIDDLE, M. MURRAY, K. BYTH, AND G. C. FARRELL. Pretranslational regulation of P-450 genes is responsible for disease specific changes of individual P-450 enzymes among patients with cirrhosis. Biochem. Pharmacol 49: 873-881, 1995.
79. GILLAM, E. M., Z. GUO, AND F. P. GUENGERICH. Expression of modified human cytochrome P-450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch. Biochem. Biophys. 312: 59-66, 1994.
80. GIRRE, C., D. LUCAS, E. HISPARD, C. MENEZ, S. DALLY, AND J. F. MENEZ. Assessment of cytochrome P-4502E1 induction in alcoholic patient by chlorzoxazone pharmacokinetics. Biochem. Pharmacol. 47: 1503-1508, 1994.
81. GORSKY, L. D., D. R. KOOP, AND M. J. COON. On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. J. Biol. Chem. 259: 6812-6817, 1984.
82. GRUENKE, L. D., K. KONOPKA, D. R. KOOP, AND L. WASKELL. Characterization of halothane oxidation by hepatic microsomes and purified cytochrome P-450 using gas chromatographic mass spectrometric assay. J. Pharmacol. Exp. Ther: 246: 454-459, 1988.
83. GUENGERICH, F. P. Reactions and significance of cytochrome P-450 enzymes. J. Biol. Chem. 266: 10019-10022, 1991.
84. GUENGERICH, F. P., D. H. KIM, AND M. IWASAKI. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4: 168-179, 1991.
85. GUENGERICH, F. P., AND C. G. TURVY. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256: 1189-1194, 1991.
86. HA, H. P., J. CHEN, A. U. FREIBURGHAUS, AND F. FOLLATH. Metabolism of theophylline by cDNA expressed human cytochromes P-450. Br. J. Clin. Pharmacol. 39: 321-326, 1995.
87. HASUMURA, Y., R. TESCHKE, AND C. S. LIEBER. Increased carbon tetrachloride hepatotoxicity, and its mechanism, after chronic ethanol consumption. Gastroenterology 66: 226-234, 1974.
88. HASUMURA, Y., R. TESCHKE, AND C. S. LIEBER. Hepatic microsomal ethanol oxidizing system (MEOS): dissociation from reduced nicotinamide adenine dinucleotide phosphate-oxidase and possible role of form 1 of cytochrome P-450. J. Pharmacol. Exp. Ther. 194: 469-474, 1975.
89. HAYASHI, S., J. WATANABE, AND K. KANAME. Genetic polymorphism in the 5′-flanking region change transcriptional regulation of the human cytochrome P-450IIE1 gene. J. Biochem. 110: 559-565, 1991.
90. HAYES, M. A., T. H. RUSHMORE, AND M. T. GOLDBERG. Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydramine by diallylsulfide, a component of garlic oil. Carcinogenesis 8: 1155-1157, 1987.
91. HERBST, J., U. KOSTER, R. KERSSEBAUM, AND W. DEKANT. Role of P-4502E1 in the metabolism of 1,1,2,2-tetrafluoro-1(2,2,2-trinuoroethoxy)ethane. Xenobiotica 24: 507-516, 1994.
92. HETU, C., A. DUMONT, AND J. G. JOLY. Effect of chronic ethanol administration on bromobenzene liver toxicity in the rat. Toxicol. Appl. Pharmacol. 67: 166-167, 1983.
93. HETU, C., AND J. G. JOLY. Differences in the duration of the enhancement of liver mixed function oxidase activities in ethanol fed rats after withdrawal. Biochem. Pharmacol. 34: 1211-1216, 1985.
94. HILDEBRANDT, A. G., AND M. SPECK. Investigations on metabolism of ethanol in rat liver microsomes (Abstract). Arch. Pharmacol. 277, Suppl.: 165, 1973.
95. HILDEBRANDT, A. G., M. SPECK, AND I. ROOTS. The effects of substrates of mixed function oxidase on ethanol oxidation in rat liver microsomes. Naunyn-Schmiedebergs Arch. Pharmacol. 281: 371-382, 1974.
96. HIRVONEN, A., K. HUSGAFVEL-PURSIAINEN, S. ANTTILA, A. KARJALAINEN, AND H. VAINIO. The human CYP2E1 gene and lung cancer: Dra I and Rsa I restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 14: 85-88, 1993.
97. HOERNER, M., U. J. BEHRENS, T. WORNER, AND C. S. LIEBER. Humoral immune response to acetaldehyde adducts in alcoholic patients. Res. Commun. Chem. Pathol. Pharmacol. 54: 3-12, 1986.
98. HOFFMAN, J., K. KONOPKA, C. BUCKHORN, D. R. KOOP, AND L. WASKELL. Ethanol inducible cytochrome P-450 in rabbits metabolizes enflurane. Br. J. Anaesth. 63: 103-108, 1989.
99. HONG, J.-Y., S. M. NING, B.-L. MA, M.-J. LEE, J. PAN, AND C. S. YANG. Roles of pituitary hormones in the regulation of hepatic cytochrome P-450IIE1 in rats and mice. Arch. Biochem. Biophys. 281: 132-138, 1990.
100. HYLAND, R., A. GESCHER, K. THUMMEL, C. SCHILLER, P. JHEETA, K. MYNETT, A. SMITH, AND J. MRAZ. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P-450 isoenzyme CYP2E1. Mol. Pharmacol. 41: 259-266, 1992.
101. INGELMAN-SUNDBERG, M., AND I. JOHANSSON. Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol inducible and other forms of rabbit liver microsomal cytochromes P-450. J. Biol. Chem. 259: 6447-6458, 1984.
102. INGELMAN-SUNDBERG, M., I. JOHANSSON, K. E. PENTTILA, H. GLAUMANN, AND K. O. LINDROS. Centrilobular expression of ethanol inducible cytochrome P-450 (IIE1) in rat liver. Biochem. Biophys. Res. Commun. 157: 55-60, 1988.
103. ISERI, O. A., L. S. GOTTLIEB, AND C. S. LIEBER. The ultrastructure of ethanol induced fatty liver (Abstract). Federation Proc. 23: 579, 1964.
104. ISERI, O. A., L. S. GOTTLIEB, AND C. S. LIEBER. The ultrastructure of fatty liver induced by prolonged ethanol ingestion. Am. J. Pathol. 48: 535-555, 1966.
105. ISHIZAKI, H., J. F. BRADY, S. M. NING, AND C. S. YANG. Effect of phenethyl isothiocyanate on microsomal N-nitroxodimethylamine metabolism and other monooxygenase activities. Xenobiotica 20: 255-264, 1990.
106. ISRAEL, Y., E. HURWITZ, O. NIEMELA, AND R. ARNON. Monoclonal and polyclonal antibodies against acetaldehyde containing epitopes in acetaldehyde-protein adducts. Proc. Natl. Acad. Sci. USA 83: 7923-7927, 1986.
107. ITO, D., AND C. S. LIEBER. Ethanol metabolism in deermice: role of extrahepatic alcohol dehydrogenase. Alcohol. Clin. Exp. Res. 17: 919-925, 1993.
108. IWAHASHI, K., Y. MATSUO, H. SUWAKI, K. NAKAMURA, AND Y. ICHIKAWA. CYP2E1 and ALDH2 genotypes and alcohol dependence in Japanese. Alcohol. Clin. Exp. Res. 19: 564-566, 1995.
109. JAYYOSI, Z., D. KNOBLE, M. MUC, J. ERICK, P. E. THOMAS, AND M. KELLEY. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. J. Pharmacol. Exp. Ther. 273: 1156-1161, 1995.
110. JEONG, K.-S., I. J. LEE, B. J. ROBERTS, Y. SOH, J. K. YOO, J. W. LEE, AND B. J. SONG. Transcriptional inhibition of cytochrome P-4502E1 by a synthetic compound, YH439. Arch. Biochem. Biophys. 326: 137-144, 1996.
111. JOHANSSON, I. J., G. EKSTROM, B. SCHOLTE, D. PUZYCKI, H. JORNVALL, AND M. INGLEMAN-SUNDBERG. Ethanol, fasting, and acetone inducible cytochromes P-450 in rat liver: regulation and characteristics of enzymes belonging to the IIB and IIE gene subfamilies. Biochemistry 27: 1925-1934, 1988.
112. JOHANSSON, I. J., E. ELIASSON, C. NORSTEN, AND M. INGELMAN-SUNDBERG. Hydroxylation of acetone by ethanol- and acetone-inducible cytochrome P-450 in liver microsomes and reconstituted membranes. FEBS Lett. 196: 59-64, 1986.
113. JOHANSSON, I. J., AND M. INGELMAN-SUNDBERG. Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res. 48: 5387-5390, 1988.
114. JOLY, J. G., AND C. HETU. Effects of chronic ethanol administration in the rat. Relative dependency on dietary lipids. I. Induction of hepatic drug-metabolism enzymes in vitro. Biochem. Pharmacol. 24: 1475-1480, 1975.
115. JOLY, J. C., AND C. HETU. Effects of chronic ethanol administration in the rat: relative dependency on dietary lipids. II. Paradoxical role of linoleate in the induction of hepatic drug metabolizing enzymes in vitro. Can. J. Physiol. Pharmacol. 55: 34-41, 1977.
116. JOLY, J. G., C. HETU, P. MAVIER, AND J. P. VILLENEUVE. Mechanisms of induction of hepatic drug metabolizing enzymes by ethanol. I. Limited role of microsomal phospholipids. Biochem. Pharmacol. 25: 1995-2001, 1976.
117. JOLY, J. G., H. ISHII, AND C. S. LIEBER. Microsomal cyanide-binding cytochrome: its role in hepatic ethanol oxidation (Abstract). Gastroenterology 62: 174, 1972.
118. JOLY, J. G., J. P. VILLENEUVE, AND P. MAVIER. Chronic ethanol administration induces a form of cytochrome P-450 with specific spectral and catalytic properties. Alcohol. Clin. Exp. Res. 1: 17-20, 1977.
119. JONES, B. M., AND A. PARADES. Circadian variation of ethanol metabolism in alcoholics. Br. J. Addict. 69: 3-10, 1974.
120. KATO, S., J. ALDERMAN, AND C. S. LIEBER. Ethanol metabolism in alcohol dehydrogenase deficient deermice is mediated by the microsomal ethanol oxidizing system, not by catalase. Alcohol Alcohol. 1, Suppl.: 231-234, 1987.
121. KATO, S., J. ALDERMAN, AND C. S. LIEBER. Respective roles of the microsomal ethanol oxidizing system (MEOS) and catalase in ethanol metabolism by deermice lacking alcohol dehydrogenase. Arch. Biochem. Biophys. 254: 586-591, 1987.
122. KATO, S., J. ALDERMAN, AND C. S. LIEBER. In vivo role of the microsomal ethanol oxidizing system in ethanol metabolism by deermice lacking alcohol dehydrogenase. Biochem. Pharmacol. 37: 2706-2708, 1988.
123. KATO, S., P. G. SHIELDS, N. E. CAPORASO, R. N. HOOVER, B. F. TRUMP, H. SUGIMURA, A. WESTON, AND C. C. HARRIS. Cytochrome P-450IIE1 genetic polymorphisms, radical variation, and lung cancer risk. Cancer Res. 52: 6712-6715, 1992.
124. KAZAKOFF, K., P. IVERSEN, T. LAWSON, J. BARON, F. P. GUENGERICH, AND P. M. POUR. Involvement of cytochrome P-450 2E1-like isoform in the activation of N-nitroso(2-oxopropyl)amine in the rat nasal mucosa. Eur. J. Cancer B Oral Oncol. 30B: 179-185, 1994.
125. KEDDERIS, G. L., R. BATRA, AND D. R. KOOP. Epoxidation of acrylonitrile by rat and human cytochromes P-450. Chem. Res Toxicol. 6: 866-871, 1993.
126. KEILIN, D., AND E. F. HARTREE. Properties of catalase: catalysis of coupled oxidation of alcohols. Biochem. J. 39: 293-301, 1945.
127. KHAN, S., AND P. J. O'BRIEN. Molecular mechanisms of tirapazamine (SR 4233, Win 59075)-induced hepatocyte toxicity under low oxygen concentrations. Br. J. Cancer 71: 780-785, 1995.
128. KHANI, S. C., T. D. PORTER, AND M. J. COON. Isolation and partial characterization of the gene for cytochrome P-450 3a (P-450ALC) and a second closely related gene. Biochem. Biophys. Res. Commun. 150: 10-17, 1988.
129. KHANI, S. C., P. G. ZAPHIROPOULOS, V. S. FUJITA, T. D. PORTER, D. R. KOOP, AND M. J. COON. cDNA and derived amino acid sequence of ethanol-inducible rabbit liver cytochrome P-450 isozyme 3a (P-450ALC). Proc. Natl. Acad. Sci. USA 84: 638-642, 1987.
130. KHARASCH, E. D. , A. S. ARMSTRONG, K. GUNN, A. ARTRU, K. COX, AND M. D. KAROL. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P-450 2E1 in fluoride and hexafluoroisopropanol formation. Anesthesiology 82: 1379-1388, 1995.
131. KHARASCH, E. D., D. C. HANKINS, AND K. E. THUMMEL. Human kidney methoxyflurane and sevoflurane metabolism. Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity. Anesthesiology 82: 689-699, 1995.
132. KHARASCH, E. D., K. E. THUMMEL, D. MAUTZ, AND S. BOSSE. Clinical enflurane metabolism by cytochrome P-450 2E1. Clin. Pharmacol. Ther. 55: 434-440, 1994.
133. KIM, S. G., J. Y. KWAK, J. W. LEE, R. F. NOVAK, S. S. PARK, AND N. D. KIM. Malotilate, a hepatoprotectant, suppresses CYP2E1 expression in rats. Biochem. Biophys. Res. Commun. 200: 1414-1420, 1994.
134. KIM, S. G., AND R. F. NOVAK. Induction of rat hepatic P-450IIE1 (CYP 2E1) by pyridine: evidence for a role of protein synthesis in the absence of transcriptional activation. Biochem. Biophys. Res. Commun. 166: 1072-1079, 1990.
135. KIM, S. G., S. E. SHEHIN, J. C. STATES, AND R. F. NOVAK. Evidence for increased translational efficiency in the induction of P-450IIE1 by solvents: analysis of P-450IIE1 mRNA polyribosomal distribution. Biochem. Biophys. Res. Commun. 172: 767-774, 1990.
136. KIM, S. G., D. E. WILLIAMS, E. G. SCHUEETZ, P. S. GUZELIAN, AND R. F. NOVAK. Pyridine induction of cytochrome P-450 in the rat: role of P-450j (alcohol inducible form) in pyridine N-oxidation. J. Pharmacol. Exp. Ther. 246: 1175-1182, 1988.
137. KNECHT, K. T., R. G. THURMAN, AND P. R. MASON. Role of superoxide and trace transition metals in the production of α-hydroxyethyl radical from ethanol by microsomes from alcohol dehydrogenase-deficient deermice. Arch. Biochem. Biophys. 303: 339-348, 1993.
138. KOIVISTO, T., V. M. MISHIN, K. M. MAK, P. A. COHEN, AND C. S. LIEBER. Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells. Alcohol. Clin. Exp. Res. 20: 207-212, 1996.
139. KOOP, D. R. Hydroxylation of p-nitrophenol by rabbit ethanol inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol. 29: 399-404, 1986.
140. KOOP, D. R. Inhibition of ethanol-inducible cytochrome P-450IIE1 by 3-amino-1,2,4-triazole. Chem. Res. Toxicol. 3: 377-383, 1990.
141. KOOP, D. R. Oxidative and reductive metabolism by cytochrome P-450 2E1. FASEB J. 6: 724-730, 1992.
142. KOOP, D. R., AND J. P. CASAZZA. Identification of ethanol-inducible P-450 enzyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J. Biol. Chem. 260: 13607-13612, 1985.
143. KOOP, D. R., A. CHERNOSKY, AND E. P. BRASS. Identification and induction of cytochrome P-450 2E1 in rat Kupffer cells. J. Pharmacol. Exp. Ther. 258: 1072-1076, 1991.
144. KOOP, D. R., AND M. J. COON. Ethanol oxidation and toxicity: role of alcohol P-450 oxygenase. Alcohol. Clin. Exp. Res. 10, Suppl.: 44s-49s, 1986.
145. KOOP, D. R., B. L. CRUMP, G. D. NORDBLOM, AND M. J. COON. Immunochemical evidence for induction of the alcohol oxidizing cytochrome P-450 of rabbit liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole, and isoniazid. Biochemistry 82: 4065-4069, 1985.
146. KOOP, D. R., C. L. LAETHEM, AND G. G. SCHNIER. Identification of ethanol-inducible P-450 isozyme 3a (P-450IIE1) as a benzene and phenol hydroxylase. Toxicol. Appl. Pharmacol. 98: 278-288, 1989.
147. KOOP, D. R., E. T. MORGAN, G. E. TARR, AND M. J. COON. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol treated rabbits. J. Biol. Chem. 257: 8472-8480, 1982.
148. KOOP, D. R., AND D. J. TIERNEY. Multiple mechanisms in the regulation of ethanol inducible cytochrome P-450IIE1. Bioessays 9: 429-435, 1990.
149. KOSTER, U., P. SPEERSCHNEIDER, R. KERSSEBAUM, H. WITTMANN, AND W. DEKANT. Role of cytochrome P-450 2E1 in the metabolism of 1,1,2,3,3-hexafluoropropyl methyl ether. Drug Metab. Dispos. 22: 667-672, 1994.
150. KOSTRUBSKY, V. E., S. C. STROM, S. G. WOOD, S. A. WRIGHTON, P. R. SINCLAIR, AND J. F. SINCLAIR. Research report: ethanol and isopentanol increased CYP3A and CYP2E in primary cultures of human hepatocytes. Arch. Biochem. Biophys. 322: 516-520, 1995.
151. KREBS, H. A., AND J. R. PERKINS. The physiological role of liver alcohol dehydrogenase. Biochem. J. 118: 635-644, 1970.
152. KRIKUN, G., AND A. CEDERBAUM. Effect of chronic ethanol consumption on microsomal lipid peroxidation: role of iron and comparison between controls. FEBS Lett. 208: 292-296, 1986.
153. KUBOTA, S., J. M. LASKER. AND C. S. LIEBER. Molecular regulation of ethanol inducible cytochrome P-450-IIE1 in hamsters. Biochem. Biophys. Res. Commun. 150: 304-310, 1988.
154. KWAK, M. K., S. G. KIM, J. Y. KWAK, R. F. NOVAK, AND N. D. KIM. Inhibition of cytochrome P-4502E1 expression by organosulfur compounds allylsulfide allylmercaptan and allymethylsulfide in rats. Biochem. Pharmacol. 47: 531-539, 1994.
155. LAETHEM, R. M., M. BALAZY, J. R. FALCK, C. L. LAETHEM, AND D. R. KOOP. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol inducible cytochrome P-450 2E1. J. Biol. Chem. 26: 12912-12918, 1993.
156. LANE, B. P., AND C. S. LIEBER. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am. J. Pathol. 49: 593-603, 1966.
157. LANE, B. P., AND C. S. LIEBER. Effects of butylated hydroxytoluene on the ultrastructure of rat hepatocytes. Lab. Invest. 16: 341-348, 1967.
158. LASKER, J. M., J. RAUCY, S. KUBOTA, B. P. BLOSWICK, M. BLACK, AND C. S. LIEBER. Purification and characterization of human liver cytochrome P-450 ALC. Biochem. Biophys. Res. Commun. 148: 232-238, 1987.
159. LASKER, J. M., M. TSUTSUMI, B. P. BLOSWICK, AND C. S. LIEBER. Characterization of benzoflavone (BF) inducible hamster liver cytochrome P-450 isozyme catalytically similar to cytochrome P-450-ALC (Abstract). Hepatology 1: 432, 1987.
160. LEE, R. P., AND P. G. FORKERT. In vitro biotransformation of 1,1-dichloroethylene by hepatic cytochrome P-450 2E1 in mice. J. Pharmacol. Exp. Ther. 270: 371-376, 1994.
161. LEO, M. A., S. IIDA, AND C. S. LIEBER. Retinoic acid metabolism by a system reconstituted with cytochrome P-450. Arch. Biochem. Biophys. 234: 305-312, 1984.
162. +-dependent retinol dehydrogenase in liver microsomes. Arch. Biochem. Biophys. 259: 241-249, 1987.
163. LEO, M. A., J. M. LASKER, J. L. RAUCY, C. I. KIM, M. BLACK, AND C. S. LIEBER. Metabolism of retinol and retinoic acid by human liver cytochrome P-450IIC8. Arch. Biochem. Biophys. 269: 305-312, 1989.
164. LEO, M. A., AND C. S. LIEBER. Hepatic vitamin A depletion in alcoholic liver injury. N. Engl. J. Med. 307: 597-601, 1982.
165. LEO, M. A., AND C. S. LIEBER. New pathway for retinol metabolism in liver microsomes. J. Biol. Chem. 260: 5228-5231, 1985.
166. LEO, M. A., AND C. S. LIEBER. Hypervitaminosis A: a liver lover's lament. Hepatology 8: 412-417, 1988.
167. LEO, M. A., N. LOWE, AND C. S. LIEBER. Decreased hepatic vitamin A after drug administration in humans and in rats. Am. J. Clin. Nutr. 40: 1131-1136, 1984.
168. LEO, M. A., N. LOWE, AND C. S. LIEBER. Potentiation of ethanol-induced hepatic vitamin A depletion by phenobarbital and butylated hydroxytoluene. J. Nutr. 117: 70-76, 1987.
169. LEO, M. A., M. SATO, AND C. S. LIEBER. Effect of hepatic vitamin A depletion on the liver in men and rats. Gastroenterology 84: 562-572, 1983.
170. LEREBOULLET, J., G. BARRES, AND J. P. BRIARD. La courbe d'alcoolèmie de Widmark est-elle toujours fiable? Bull. Acad. Natl. Med. 160: 312-315, 1976.
171. LEVIN, W., D. RYAN, S. WEST, AND A. Y. H. LU. Preparation of partially purified lipid depleted cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase from rat liver. J. Biol. Chem. 249: 1747-1754, 1974.
172. 5. Arch. Biochem. Biophys. 248: 158-165, 1986.
173. LIEBER, C. S. Pathogenesis and early diagnosis of alcoholic liver injury. N. Engl. J. Med. 298: 888-893, 1978.
174. LIEBER, C. S. Microsomal ethanol oxidizing system (MEOS) Enzyme 37: 45-56, 1987.
175. LIEBER, C. S. Biochemical and molecular basis for alcohol-induced injury to liver and other tissues. N. Engl. J. Med. 319: 1639-1650, 1988.
176. LIEBER, C. S. Perspectives: do alcohol calories count? Am. J. Clin. Nutr. 54: 976-982, 1991.
177. LIEBER, C. S. Medical and Nutritional Complications of Alcoholism: Mechanisms and Management. New York: Plenum, 1992.
178. LIEBER, C. S. Alcohol and the liver: 1994 update. Gastroenterology 106: 1085-1105, 1994.
179. LIEBER, C. S. Medical disorders of alcoholism. N. Engl. J. Med. 333: 1058-1965, 1995.
180. LIEBER, C. S. Role of oxidative stress and antioxidant therapy in alcoholic and non-alcoholic liver diseases. In: Advances in Pharmacology, edited by H. Sies. San Diego, CA: Academic, 1996, vol. 38, p. 601-628.
181. LIEBER, C. S. Pathogenesis and treatment of liver fibrosis: 1997 update. Dig. Dis. 15: 42-66, 1997.
182. LIEBER, C. S., E. BARAONA, R. HERNANDEZ-MUNOZ, S. KUBOTA, N. SATO, S. KAWANO, T. MATSUMURA, AND N. INATOMI. Impaired oxygen utilization: a new mechanism for the hepatotoxicity of ethanol in sub-human primates. J. Clin. Invest. 83: 1682-1690, 1989.
183. LIEBER, C. S., AND L. M. DECARLI. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science Wash. DC 162: 917-918, 1968.
184. LIEBER, C. S., AND L. M. DECARLI, Hepatic microsomal ethanol oxidizing system. In vivo characteristics and adaptive properties in vivo. J. Biol. Chem. 245: 2505-2512, 1970.
185. LIEBER, C. S., AND L. M. DECARLI. Reduced nicotinamide-adenine dinucleotide phosphate oxidase: activity enhanced by ethanol consumption. Science Wash. DC 170: 78-80, 1970.
186. LIEBER, C. S., AND L. M. DECARLI. The role of the hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo. J. Pharmacol. Exp. Ther. 181: 279-287, 1972.
187. LIEBER, C. S., AND L. M. DECARLI. The significance and characterization of hepatic microsomal ethanol oxidation in the liver. Drug Metab. Dispos. 1: 428-440, 1973.
188. LIEBER, C. S., AND L. M. DECARLI. Oxidation of ethanol by hepatic microsomes of acatalasemic mice. Biochem. Biophys. Res. Commun. 60: 1187-1192, 1974.
189. LIEBER, C. S., L. M. DECARLI, K. M. MAK, C. I. KIM, AND M. A. LEO. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 12: 1390-1398, 1990.
190. LIEBER, C. S., A. GARRO, M. A. LEO, K. M. MAK, AND T. M. WORNER. Alcohol and cancer. Hepatology 6: 1005-1019, 1986.
191. LIEBER, C. S., J. M. LASKER, L. M. DECARLI, J. SAELI, AND T. WOJTOWICZ. Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system. J. Pharmacol. Exp. Ther. 247: 791-795, 1988.
192. LIEBER, C. S., M. A. LEO, S. I. ALEYNIK, M. K. ALEYNIK, AND L. M. DECARLI. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. Alcohol. Clin. Exp. Res. In press.
193. LIEBER, C. S., S. J. ROBINS, J. LI, L. M. DECARLI, K. M. MAK, J. M. FASULO, AND M. A. LEO. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 106: 152-159, 1994.
194. LIEBER, C. S., E. RUBIN, AND L. M. DECARLI. Hepatic microsomal ethanol oxidizing system (MEOS): differentiation from alcohol dehydrogenase and NADPH oxidase. Biochem. Biophys. Res. Commun. 40: 858-865, 1970.
195. LIN, R. C., R. S. SMITH, AND L. LUMENG. Detection of a protein-acetaldehyde adduct in the liver of rats fed alcohol chronically. J. Clin. Invest. 81: 615-619, 1988.
196. LOIZOU, G. D., G. URBAN, W. DEKANT, AND M. W. ANDERS. Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123). Drug Metab. Dispos. 22: 511-517, 1994.
197. LUCAS, D., F. BERTHOU, Y. DREANO, P. LOZACH, A. VOLANT, AND J. F. MENEZ. Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples. Alcohol. Clin. Exp. Res. 17: 900-905, 1993.
198. LUCAS, D., C. MENEZ, C. GIRRE, P. BODENEZ, E. HISPARD, AND J. F. MENEZ. Decrease in cytochrome P-4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol. Clin. Exp. Res. 19: 362-366, 1995.
199. MA, X., E. BARAONA, AND C. S. LIEBER. Alcohol consumption 2 enhances fatty acid ω-oxidation, with a greater increase in males than in females. Hepatology 18: 1247-1253, 1993.
200. MA, X., J. ZHAO, AND C. S. LIEBER. Polyenylphosphatidylcholine attenuates nonalcoholic hepatic fibrosis and accelerates its regression. J. Hepatol. 24: 604-613, 1996.
201. MAEZAWA, Y., M. YAMAUCHI, AND G. TODA. Association between restriction fragment length polymorphism of the human cytochrome P-450IIE1 gene and susceptibility to alcoholic liver cirrhosis. Am. J. Gastroenterol. 89: 561-565, 1994.
202. MAEZAWA, Y., M. YAMAUCHI, G. TODA, H. SUZUKI, AND S. SUKURAI. Alcohol metabolizing enzyme polymorphisms and alcoholism in Japan. Alcohol. Clin. Exp. Res. 19: 951-954, 1995.
203. 202a. MATSUZAKI, S., AND C. S. LIEBER. Increased susceptibility of hepatic mitochondria to the toxicity of acetaldehyde after ethanol consumption. Biochem. Biophys. Res. Commun. 75: 1059-1065, 1977.
204. MCCOY, G. D., AND D. R. KOOP. Reconstitution of rabbit liver microsomal N-nitrosopyrrolidine α-hydroxylase activity. Cancer Res. 48: 3987-3992, 1988.
205. MCGEHEE, R. E., M. J. J. RONIS, R. M. COWHERD, M. INGELMAN-SUNDBERG, AND T. M. BADGER. Characterization of cytochrome P450 2E1 induction in a rat hepatoma FGC-4 cell model by ethanol. Biochem. Pharmacol. 48: 1823-1833, 1994.
206. MELDOLESI, J. On the significance of the hypertrophy of the smooth endoplasmic reticulum in liver cells after administration of drugs. Biochem. Pharmacol. 16: 125-131, 1967.
207. MEZEY, E., J. J. POTTER, AND W. D. REED. Ethanol oxidation by a component of liver microsomes rich in cytochrome P-450. J. Biol. Chem. 248: 1183-1187, 1973.
208. MIKALSEN, A., J. ALEXANDER, H. WALLIN, M. INGELMAN-SUNDBERG, AND R. A. ANDERSEN. Reductive metabolism and protein binding of chromium (VI) by P-450 protein enzymes. Carcinogenesis 12: 825-831, 1991.
209. MILLER, K. W., AND C. S. YANG. Studies on the mechanisms of induction of N-nitrosodimethylamine demethylase by fasting, acetone, and ethanol. Arch. Biochem. Biophys. 229: 483-491, 1984.
210. MISHIN, V. M., T. KOIVISTO, AND C. S. LIEBER. The determination of cytochrome P-450 2E1 dependent p-nitrophenol hydroxylation by high performance liquid chromatography with electrochemical detection. Anal. Biochem. 233: 212-215, 1996.
211. MISRA, P. S., A. LEFÈVRE, H. ISHII, E. RUBIN, AND C. S. LIEBER. Increase of ethanol meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats. Am. J. Med. 51: 346-351, 1971.
212. MITCHELL, J. R., C. MACK, E. MEZEY, AND W. C. MADDREY. The effects of variation in dietary protein and ethanol on hepatic microsomal drug metabolism in the rat. Hepatology 1: 336-340, 1981.
213. MIWA, G. T., W. LEVIN, P. E. THOMAS, AND A. Y. H. LU. The direct oxidation of ethanol by a catalase and alcohol dehydrogenase free reconstituted system containing cytochrome P-450. Arch. Biochem. Biophys. 187: 464-475, 1978.
214. MORGAN, E. T., D. R. KOOP, AND M. J. COON. Catalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. Oxidation of alcohols. J. Biol. Chem. 257: 13951-13957, 1982.
215. MORGAN, E. T., D. R. KOOP, AND M. J. COON. Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen. Biochem. Biophys. Res. Commun. 112: 8-13, 1983.
216. MORIMOTO, M., R. C. REITZ, R. J. MORIN, K. NGUYEN, M. INGELMAN-SUNDBERG, AND S. W. FRENCH. CYP2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet. J. Nutr. 125: 2953-2964, 1995.
217. NAKAJIMA, T., E. ELOVAARA, T. OKINO, H. V. GELBOIN, M. KLOCKARS, V. RIIHIMAKI, T. AOYAMA, AND H. VAINIO. Different contributions of cytochromes P-450 2E1 and P-450 2B1/2 to chloroform hepatotoxicity in rat. Toxicol. Appl. Pharmacol. 133: 215-222, 1995.
218. NAKAJIMA, T., T. OKINO, AND A. SATO. Kinetic studies on benzene metabolism in rat liver: possible presence of three forms of benzene metabolizing enzymes in the liver. Biochem. Pharmacol. 36: 2799-2804, 1987.
219. NAKURA, H., S. ITOH, H. KUSANO, H. ISHIZONE, S. IMAKOKA, Y. FUNAE, T. YOKOI, AND T. KAMATAKI. Decrease in the content of cytochrome P450IIE by fasting in liver microsomes of house musk shrew (Suncus murinus). Biochem. Pharmacol. 43: 1907-1910, 1992.
220. NANJI, A. A., S. ZHAO, R. G. LAMB, A. J. DENNENBERG, S. M. HOSSEIN, H. SADRZADEH, AND D. J. WAXMAN. Changes in cytochromes P-450, 2E1, 2B1, and 4A and phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: relationship to dietary fats and pathologic liver injury. Alcohol. Clin. Exp. Res. 18: 902-908, 1994.
221. NANJI, A. A., S. ZHAO, R. G. LAMB, H. SADRZADEH, A. J. DANNENBERG, AND D. J. WAXMAN. Changes in microsomal phospholipases and arachidonic acid in experimental alcoholic liver injury: relationship to cytochrome P-450 2E1 induction and conjugated diene formation. Alcohol. Clin. Exp. Res. 17: 598-603, 1993.
222. NEBERT, D. W., M. ADESNIK, M. J. COON, R. W. ESTABROOK, F. J. GONZALEZ, P. GUENGERICH, I. C. GUNSALUS, E. F. JOHNSON, B. KEMPER, W. LEVIN, I. R. PHILLIPS, R. SATO, AND M. R. WATERMAN. The P-450 gene superfamily: recommended nomenclature. DNA 6: 1-11, 1987.
223. NEBERT, D. W., D. R. NELSON, M. ADESNIK, M. J. COON, R. W. ESTABROOK, F. J. GONZALEZ, F. P. GUENGERICH, I. C. GUNSALUS, E. F. JOHNSON, B. KEMPER, W. LEVIN, I. R. PHILLIPS, R. SATO, AND M. R. WATERMAN. The P-450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA 8: 1-13, 1989.
224. NELSON, D. R., T. KAMATAKI, D. J. WAXMAN, F. P. GUENGERICH, R. W. ESTABROOK, R. FETEREISEN, F. J. GONZALEZ, M. J. COON, I. C. GUNSALUS, O. GOTOH, K OKUDA, AND D. W. NEBERT. The P-450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12: 1-51, 1993.
225. NOMURA, F., AND C. S. LIEBER. Binding of acetaldehyde to rat liver microsomes: enhancement after chronic alcohol consumption. Biochem. Biophys. Res. Commun. 100: 131-137, 1981.
226. NORDMANN, R., C. RIBIERE, AND H. ROUACH. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radical Biol. Med. 12: 219-240, 1992.
227. OHNISHI, K., AND C. S. LIEBER. Reconstitution of the microsomal ethanol oxidizing system (MEOS): qualitative and quantitative changes of cytochrome P-450 after chronic ethanol consumption. J. Biol. Chem. 252: 7124-7131, 1977.
228. OHNISHI, K., AND C. S. LIEBER. Respective role of superoxide and hydroxyl radical in the activity of the reconstituted microsomal ethanol oxidizing system. Arch. Biochem. Biophys. 191: 798-803, 1978.
229. OLSON, M. J., S. G. KIM, C. A. REIDY, J. T. JOHNSON, AND R. F. NOVAK. Oxidation of 1,1,1,2-tetrafluoroethane in rat liver microsomes is catalyzed primarily by cytochrome P-450IIE1. Drug Metab. Dispos. 19: 298-303, 1990.
230. ONO, S., T. HATANAKA, H. HOTTA, M. TSUSUI, T. SATOH, AND F. Y. GONZALEZ. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 5: 143-150, 1995.
231. ORME-JOHNSON, W. H., AND D. M. ZIEGLER. Alcohol mixed function oxidase activity of mammalian liver microsomes. Biochem. Biophys. Res. Commun. 21: 78-82, 1965.
232. OWEN, O. E., V. E. TRAPP, C. L. SKUTCHES, M. A. MOZZOLI, R. D. HOIELDTKE, G. BODEN, AND G. A. REICHARD, JR. Acetone metabolism during diabetic ketoacidosis. Diabetes 31: 242-248, 1982.
233. PAN, J., J.-Y. HONG, AND C. S. YANG. Posttranscriptional regulation of mouse renal cytochrome P-450 2E1 by testosterone. Arch. Biochem. Biophys. 299: 110-115, 1992.
234. PATTEN, C. J., H. ISHIZAKI, T. AOYAMA, M. LEE, S. M. NING, W. HUANG, F. J. GONZALEZ, AND C. S. YANG. Catalytic properties of human cytochromes P-450 2E1 produced by cDNA expression in mammalian cells. Arch. Biochem. Biophys. 299: 163-171, 1992.
235. PENG, H. M., G. M. RANER, A. D. VAZ, AND M. J. COON. Oxidative cleavage of esters and amides to carbonyl products by cytochrome P-450. Arch. Biochem. Biophys. 318: 333-339, 1995.
236. PERSSON, I., I. JOHANSSON, H. BERGLING, M. L. DAHL, J. SEIDEGARD, R. RYLANDER, A. RANNUG, J. HABERG, AND H. SUNDBERG. Genetic polymorphism of cytochrome P-4502E1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett. 319: 207-211, 1993.
237. PERSSON, J. O., Y. TERELIUS, AND M. INGELMAN-SUNDBERG. Cytochrome P-450 dependent formation of reactive oxygen radicals: isozyme specific inhibition of P-450 mediated reduction of oxygen and carbon tetrachloride. Xenobiotica 20: 887-900, 1990.
238. PETER, R., R. BÖKER, P. H. BEAUNE, M. IWASAKI, F. P. GUENGERICH, AND C. S. YANG. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 3: 566-573, 1990.
239. PIKKARAINEN, P. H., AND C. S. LIEBER. Concentration dependency of ethanol elimination rates in baboons: effects of chronic alcohol consumption. Alcohol. Clin. Exp. Res. 4: 40-43, 1980.
240. PINKSTON, J. N., AND K. F. A. SONIMAN. Effect of light and fasting on the circadian variation of ethanol metabolism in the rat. J. Interdiscip. Cycle Res. 10: 185-193, 1979.
241. PIRMOHAMED, M, N. R. KITTERINGHAM, L. J. QUEST, R. L. ALLOTT, V. J. GREEN, I. T. GILMORE, AND B. K. PARK. Genetic polymorphism of cytochrome P-4502E1 and risk of alcoholic liver disease in Caucasians. Pharmacogenetics 5: 351-357, 1995.
242. PIROLA, R. C., AND C. S. LIEBER. The energy cost of the metabolics of drugs, including ethanol. Pharmacology 7: 185-196, 1972.
243. PORTER, T. D., S. C. KHANI, AND M. J. COON. Induction and tissue specific expression of rabbit cytochrome P-450IIE1 and IIE2 genes. Mol. Pharmacol. 36: 61-65, 1989.
244. RASHBA-STEP, J., N. J. TURRO, AND A. I. CEDERBAUM. Increased NADPH- and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol consumption. Arch. Biochem. Biophys. 300: 401-408, 1993.
245. RAUCY, J. L., G. CURLEY, AND S. P. CARPENTER. Use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic cytochrome P-4502E1. Alcohol. Clin. Exp. Res. 19: 1369-1375, 1995.
246. RAUCY, J. L., P. FERNANDES, M. BLACK, S. L. YANG, AND D. R. KOOP. Identification of a human liver cytochrome P-450 exhibiting catalytic and immunochemical similarities to cytochrome P-450 3a of rabbit liver. Biochem. Pharmacol. 36: 2921-2926, 1987.
247. RAUCY, J. L., J. M. LASKER, J. C. KRAMER, D. E. SALAZER, C. S. LIEBER, AND G. B. CORCORAN. Induction of P-450IIE1 in the obese rat. Mol. Pharmacol. 39: 275-280, 1991.
248. REICHARD, G. A., JR., A. C. HAFF, C. L. SKUTCHES, P. PAUL, C. P. HOLROYDE, AND O. E. OWEN. Plasma acetone metabolism in the fasting human. J. Clin. Invest. 63: 619-626, 1979.
249. REICHARD, G. A., JR., C. L. SKUTCHES, R. D. HOELDKE, AND O. W. OWEN. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 35: 668-674, 1986.
250. REINKE, L. A., E. K. LAI, AND P. B. MCCAY. Ethanol feeding stimulates trichlormethyl radical formation from carbon tetrachloride in liver. Xenobiotica 18: 1311-1318, 1988.
251. REINKE, L. A., J. M. RAU, AND P. B. MCCAY. Possible roles of free radicals in alcoholic tissue damage. Free Radical Res. Commun. 9: 205-211, 1990.
252. RIFKIND, A. B., C. LEE, T. K. CHANG, AND D. J. WAXMAN. Arachidonic acid metabolism by human cytochrome P-450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320: 380-389, 1995.
253. ROBERTS, B. J., B.-J. SONG, Y. SOH, S. S. PARK, AND S. E. SHOAF. Ethanol induces CYP2E1 by protein stabilization. J. Biol. Chem. 270: 29632-29635, 1995.
254. RONIS, M. J., J. HUANG, J. CROUCH, C. MERCADO, D. IRBY, C. R. VALENTINE, C. K. LUMPKIN, M. INGELMAN-SUNDBERG, AND T. M. BADGER. Cytochrome P-450 CYP 2E1 induction during chronic alcohol exposure occurs by a two-step mechanism associated with blood alcohol concentration in rats. J. Pharmacol. Exp. Ther. 264: 944-950, 1993.
255. RYAN, D. E., D. R. KOOP, P. E. THOMAS, M. J. COON, AND W. LEVIN. Evidence that isoniazid and ethanol induce the same microsomal cytochrome P-450 isozyme 3a. Arch. Biochem. Biophys. 246: 633-644, 1986.
256. RYAN, D. E., AND W. LEVIN. Purification and characterization of hepatic microsomal cytocnrome P-450. Pharmacol. Ther. 45: 153-239, 1990.
257. RYAN, D. E., L. RAMANTHAN, S. IIDA, P. E. THOMAS, M. HANIU, J. E. SHIVELY, C. S. LIEBER, AND W. LEVIN. Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. J. Biol. Chem. 260: 6385-6393, 1985.
258. SALASPURO, M. P., AND C. S. LIEBER. Non-ADH pathway of alcohol metabolism: its increase in activity at high ethanol concentrations and after chronic consumption (Abstract). Gastroenterology 73: A47, 1977.
259. SALASPURO, M. P., AND C. S. LIEBER. Non-uniformity of blood ethanol elimination: its exaggeration after chronic consumption. Ann. Clin. Res. 10: 294-297, 1978.
260. SALAZAR, D. E., C. L. SORGE, AND G. B. CORCORAN. Obesity as a risk factor for drug-induced organ injury. VI. Increased hepatic P-450 concentration and microsomal ethanol oxidizing activity in the obese overfed rat. Biochem. Biophys. Res. Commun. 157: 315-320, 1988.
261. SALMELA, K. S., I. G. KESSOVA, I. B. TSYRLOV, AND C. S. LIEBER. Ethanol is oxidized by human cytochromes P-4502E1, P-4501A2 and P-4503A4 (Abstract). Alcohol Clin. Exp. Res. 20: 36, 1996.
262. SATO, C., AND C. S. LIEBER. Mechanism of the preventive effect of ethanol on acetaminophen-induced hepatotoxicity. J. Pharmacol. Exp. Ther. 218: 811-815, 1981.
263. SATO, M., AND C. S. LIEBER. Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. J. Nutr. 111: 2015-2023, 1981.
264. SAVOLAINEN, M. J., E. BARAONA, P. PIKKARAINEN, AND C. S. LIEBER. Hepatic triacylglycerol synthesizing activity during progression of alcoholic liver injury in the baboon. J. Lipid Res. 25: 813-820, 1984.
265. SCHNIER, G. G., C. L. LAETHAM, AND D. R. KOOP. Identification and induction of cytochromes P-450, P-450IIE1, and P4501A1 in rabbit bone marrow. J. Pharmacol. Exp. Ther. 251: 790-796, 1989.
266. SEATON, M. J., M. H. FOLLANSBEE, AND J. A. BOND. Oxidation of 1,2-epoxy-3-butene to 1.2:3,4-diepoxybutane by cDNA-expressed human cytochromes P-450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16: 2287-2293, 1995.
267. SEEFF, L. B., B. A. CUCCHERINI, H. J. ZIMMERMAN, E. ADLER, AND S. B. BENJAMIN. Acetaminophen hepatotoxicity in alcoholics. Ann. Intern. Med. 104: 399-404, 1986.
268. SEITZ, H. K., P. CZYGAN, K. WALDHERR, S. VEITH, AND B. KOMMERELL. Ethanol and intestinal carcinogenesis in the rat. Alcohol 2: 491-494, 1985.
269. SEITZ, H. K., A. J. GARRO, AND C. S. LIEBER. Enhanced pulmonary and intestinal activation of procarcinogens and mutagens after chronic ethanol consumption in the rat. Eur. J. Clin. Invest. 11: 33-38, 1981.
270. SHAW, S., E. JAYATILLEKE, W. A. ROSS, E. R. GORDON, AND C. S. LIEBER. Ethanol induced lipid peroxidation: potentiation by long-term alcohol feeding and attenuation by methionine. J. Lab. Clin. Med. 98: 417-425, 1981.
271. SHIGETA, C. P., F. NOMURA, S. IIDA, M. A. LEO, M. R. FELDER, AND C. S. LIEBER. Ethanol metabolism in vivo by the microsomal ethanol oxidizing system in deermice lacking alcohol dehydrogenase (ADH). Biochem. Pharmacol. 33: 807-814, 1984.
272. SHIMADA, T., H. YAMAZAKI, M. MIMURA, Y. INUI, AND F. P. GUENGERICH. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270: 414-423, 1994.
273. SHIMIZU, M., J. M. LASKER, M. TSUTSUMI, AND C. S. LIEBER. Immunohistochemical localization of ethanol inducible P-450IIE1 in the rat alimentary tract. Gastroenterology 99: 1044-1053, 1990.
274. SHIMOJO, N., T. ISHIZAKI, S. IMAOKA, Y. FUNAE, S. FUJII, AND K. OKUDA. Changes in amounts of cytochrome P-450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin induced diabetes. Biochem. Pharmacol. 46: 621-627, 1993.
275. SIEGERS, C. P., K. HEIDBUCHEL, AND M. YOUNES. Influence of alcohol, dithiocarb and (+) catechin on the hepatotoxicity and metabolism of vinylidene chloride in rats. J. Appl. Toxicol. 3: 90-95, 1983.
276. SILVIA, M., L. VINCENZO, M. ARTURO, AND G. P. GIOVANNI. Microsomal metabolism of N,N-diethylacetamide and N,N-dimethylacetamide and their effects on drug metabolizing enzymes of rat liver. Biochem. Pharmacol. 48: 717-726, 1994.
277. SLATER, T. F. Free-radical mechanisms in tissue injury. Biochem. J. 222: 1-15, 1984.
278. SOHDA, T., M. SHIMIZU, S. KAMIMURA, AND M. OKUMURA. Immunohistochemical demonstration of ethanol inducible P-450 2E1 in rat brain. Alcohol Alcohol. 1B, Suppl.: 69-75, 1993.
279. SOHN, O. S., H. ISHIZAKI, C. S. YANG, AND E. S. FIALA. Metabolism of azoxymethane, methyl azoxymethanol and N-nitrosodimethylamine by cytochrome P-450IIE1. Carcinogenesis 12: 127-131, 1991.
280. SOLOMON, L. R. Evidence for the generation of transaminase inhibitor(s) during ethanol metabolism by rat liver homogenates a potential mechanism for alcohol toxicity. Biochem. Med. Metab. Biol. 38: 9-18, 1987.
281. SONG, B. J., H. V. GELBOIN, S. S. PARK, C. S. YANG, AND F. J. GONZALEZ. Complementary DNA and protein sequences of ethanol inducible rat and human cytochrome P-450s: transcriptional and posttranscriptional regulation of the rat enzyme. J. Biol. Chem. 261: 16689-16697, 1986.
282. SONG, B. J., T. MATSUNAGA, J. HARDWICK, S. S. PARK, R. I. VEECH, C. S. YANG, H. V. GELBOIN, AND F. J. GONZALEZ. Stabilization of cytochrome P-450J messenger ribonucleic acid in the diabetic rat. Mol. Endocrinol. 1: 542-547, 1987.
283. SONG, B. J., R. I. VEECH, S. S. PARK, H. V. GELBOIN, AND F. J. GONZALEZ. Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J. Biol. Chem. 264: 3568-3572, 1989.
284. SONG, B. J., R. L. VEECH, AND P. SAENGER. Cytochrome P-450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. J. Clin. Endocrinol. Metab. 71: 1036-1040, 1990.
285. SPEERSCHNEIDER, P., AND W. DEKANT. Renal tumorigenesis of 1,1-dichloroethane in mice: the role of male-specific expression of cytochrome P-450 2E1 in the renal bioactivation of 1,1-dichloroethene. Toxicol. Appl. Pharmacol. 130: 48-56, 1995.
286. STEPHENS, E. A., J. A. TAYLOR, N. KAPLAN, C.-H. YANG, L. L. HSIEH, G. W. LUCIER, AND D. A. BELL. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics 4: 185-192, 1994.
287. STURTEVANT, F. M., R. P. STURTEVANT, L. E. SCHEVING, AND J. E. PAULY. Chronopharmacokmetics of ethanol. II. Circadian rhythm in rate of blood level decline in a single subject. Naunyn-Schniedebergs Arch. Pharmacol. 293: 203-208, 1976.
288. STYLES, J. A., A. DAVIES, C. K. LIM, F. DEMATTEIS, L. A. STANLEY, I. N. WHITE, Z. X. YUAN, AND L. L. SMITH. Genotoxicity of tamoxifen, tamoxifen epoxide, and toremifene in human lymphoblastoid cells containing human cytochromesP-450S. Carcinogenesis 15: 5-9, 1994.
289. SUBRAMANIAN, U., AND A. E. AHMED. Intestinal toxicity of acrylonitrile: in vitro metabolism by intestinal cytochrome P-450 2E1. Toxicol. Appl. Pharmacol. 135: 1-8, 1995.
290. SUGIMURA, H., G. S. HAMADA, I. SUZUKI, T. IWASE, E. KIYOKAWA, I. KINO, AND S. TSUGANE. CYP1A1 and CYP2E1 polymorphism and lung cancer, case control study in Rio de Janeiro, Brazil. Pharmacogenetics 5, Suppl.: S145-S148, 1995.
291. SURBROOK, S. E., JR., AND M. J. OLSON. Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane. Drug Metab. Dispos. 20: 518-524, 1992.
292. SURH, Y. J., AND S. S. LEE. Capsaicin, a double-edged sword: toxicity, metabolism, and chemopreventive potential. Life Sci. 56: 1845-1855, 1995.
293. SVEGLIATI-BARONI, G., E. BARAONA, A. S. ROSMAN, AND C. S. LIEBER. Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases. Hepatology 20: 111-118, 1994.
294. TAKAGI, T., H. ISHII, H. TAKAHASHI, S. KATO, F. OKUNO, Y. EBIHARA, H. YAMAUCHI, Y. NAGATA, M. TASHIRO, AND M. TSUCHIYA. Potentiation of halothane hepatotoxicity by chronic ethanol administration in rat: an animal model of halothane hepatitis. Pharmacol. Biochem. Behav. 18, Suppl. 1: 461-465, 1983.
295. TAKAHASHI, H., I. JOHANSSON, S. W. FRENCH, AND M. INGELMAN-SUNDBERG. Effects of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol-inducible cytochrome P-450 (CYP2E1) in the liver of rats chronically fed ethanol. Pharmacol. Toxicol. 70: 347-352, 1992.
296. TAKAHASHI, T., J. M. LASKER, A. S. ROSMAN, AND C. S. LIEBER. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 17: 236-245, 1993.
297. TANG, B. K., F. J. GONZALEZ, AND W. KALOW. Caffeine as marker of cytochrome P-450 CYP2E1 (Abstract). In: Int. Symp. Microsomes Drug Oxidations 10th Toronto Canada 1994, p. 496.
298. TASSANEEYAKUL, W., D. BIRKETT, M. E. MCMANUS, W. TASSANEEYAKUL, M. E. VERONESE, T. ANDERSSON, R. H. TUKEY, AND J. O. MINERS. Caffeine metabolism by human hepatic cytochromes P-450: contributions of 1A2, 2E1 and 3A isoforms. Biochem. Pharmacol. 47: 1767-1776, 1994.
299. TASSANEEYAKUL, W., M. E. VERONESE, D. J. BIRKETT, F. J. GONZALEZ, AND J. O. MINERS. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem. Pharmacol. 46: 1975-1981, 1993.
300. TERELIUS, Y., AND M. INGELMAN-SUNDBERG. Metabolism of n-pentane by ethanol-inducible cytochrome P-450 in liver microsomes and reconstituted membranes. Eur. J. Biochem. 161: 303-308, 1986.
301. TERELIUS, Y., AND M. INGELMAN-SUNDBERG. Metabolism of organic solvents by ethanol inducible cytochrome P-450 (P-450IIEI). In: Cytochrome P-450. Biochemistry and Biophysics, edited by I. Schuster. London: Taylor & Francis, 1988, p. 608-611.
302. TERELIUS, Y., C. NORSTEN-HOOG, T. CRONHOLM, AND M. INGELMAN-SUNDBERG. Acetaldehyde as a substrate for ethanol inducible cytochrome P-450 (CYP2E1). Biochem. Biophys. Res. Commun. 179: 689-694, 1991.
303. TESCHKE, R., Y. HASUMURA, J.-G. JOLY, H. ISHII, AND C. S. LIEBER. Microsomal ethanol oxidizing system (MEOS): purification and properties of a rat liver system free of catalase and alcohol dehydrogenase. Biochem. Biophys. Res. Commun. 49: 1187-1193, 1972.
304. TESCHKE, R., Y. HASUMURA, AND C. S. LIEBER. Hepatic microsomal ethanol oxidizing system: solubilization, isolation and characterization. Arch. Biochem. Biophys. 163: 404-415, 1974.
305. TESCHKE, R., Y. HASUMURA, AND C. S. LIEBER. NADPH dependent oxidation of methanol, ethanol, propanol and butanol by hepatic microsomes. Biochem. Biophys. Res. Commun. 60: 851-857, 1974.
306. 2. Mol. Pharmacol. 11: 841-849, 1975.
307. TESCHKE, R., Y. HASUMURA, AND C. S. LIEBER. Hepatic microsomal alcohol oxidizing system. Affinity for methanol, ethanol and propanol. J. Biol. Chem, 250: 7397-7404, 1975.
308. TESCHKE, R., S. MATSUZAKI, K. OHNISHI, L. M. DECARLI, AND C. S. LIEBER. Microsomal ethanol oxidizing system (MEOS): current status of its characterization and its role. Alcohol. Clin. Exp. Res. 1: 7-15, 1977.
309. TESCHKE, R., F. MORENO, AND A. S. PETRIDES. Hepatic microsomal ethanol oxidizing system (MEOS): respective roles of ethanol and carbohydrates for the enhanced activity after chronic alcohol consumption. Biochem. Pharmacol. 30: 1745-1751, 1981.
310. THOMPSON, G. N. Alcoholism. Springfield, IL: Thomas, 1956.
311. THURMAN, R. G., H. G. LEY, AND R. SCHOLZ. Hepatic microsomal ethanol oxidation. Hydrogen peroxide formation and the role of catalase. Eur. J. Biochem. 25: 420-430, 1972.
312. TSUTSUMI, M., J. M. LASKER, M. SHIMIZU, A. S. ROSMAN, AND C. S. LIEBER. The intralobular distribution of ethanol-inducible P-450IIE1 in rat and human liver. Hepatology 10: 437-446, 1989.
313. TSUTSUMI, M., J. M. LASKER, T. TAKAHASHI, AND C. S. LIEBER. In vivo induction of hepatic P-4502E1 by ethanol: role of increased enzyme synthesis. Arch. Biochem. Biophys. 304: 209-218, 1993.
314. TSUTSUMI, R., M. A. LEO, C. KIM, M. TSUTSUMI, J. M. LASKER, N. LOWE, AND C. S. LIEBER. Interaction of ethanol with enflurane metabolism and toxicity: role of P-450IIE1. Alcohol. Clin. Exp. Res. 14: 174-179, 1990.
315. TSUTSUMI, M., M. SHIMIZU, J. M. LASKER, AND C. S. LIEBER. Intralobular distribution of ethanol-inducible cytochrome P-450IIE1 in liver (Abstract). Hepatology 8: 1237, 1988.
316. TSUTSUMI, M., A. TAKADA, AND J. S. WANG. Genetic polymorphism of cytochrome P-4502E1 related to the development of alcoholic liver disease. Gastroenterology 107: 1430-1435, 1994.
317. UEMATSU, F., S. IKAWA, H. KIKUCHI, I. SAGAMI, R. KANAMARA, T. ABE, K. SATOH, M. MOTOMIYA, AND M. WATANABE. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P-450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics 4: 58-63, 1994.
318. UEMATSU, F., H. KIKUCHI, M. MOTOMIYA, T. ABE, I. SAGAMI, T. OHMACHI, A. WAKUI, R. KANAMARU, AND M. WATANABE. Association between restriction fragment length polymorphism of the human cytochrome P-450IIE1 gene and susceptibility to lung cancer. Jpn. J. Cancer Res. 82: 254-256, 1991.
319. UENO, T., AND F. J. GONZALEZ. Transcriptional control of the rat hepatic CYP2E1 gene. Mol. Cell. Biol. 10: 4495-4505, 1990.
320. ULLRICH, V., P. WEBER, AND P. WOLLENBERG. Tetrahydrofurane: an inhibitor for ethanol induced liver microsomal cytochrome P-450. Biochem. Biophys. Res. Commun. 64: 808-813, 1975.
321. UMENO, M., O. W. MCBRIDE, C. S. YANG, H. V. GELBOIN, AND F. J. GONZALEZ. Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosomes mapping, and cDNA directed expression. Biochemistry 27: 9006-9013, 1988.
322. UMENO, M., B. J. SONG, C. KOZAK, H. V. GELBOIN, AND F. J. GONZALEZ. The rat P-450IIE1 gene: complete intron and exon sequence, chromosome mapping, and correlation of developmental expression with specific 5′ cytosine demethylation. J. Biol. Chem. 263: 4956-4962, 1988.
323. URBAN, G., P. SPEERSCHNEIDER, AND W. DEKANT. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P-450 2E1. Chem. Res. Toxicol. 7: 170-176, 1994.
324. VALENZUELA, A., V. FERNANDEZ, AND L. A. VIDELA. Hepatic and biliary levels of flutathione and lipid peroxides following iron overload in the rat: effect of simultaneous ethanol administration. Toxicol. Appl. Pharmacol. 70: 87-95, 1983.
325. VATSIS, K. P., AND M. P. SCHULMAN. Absence of ethanol metabolism in "acatalatic" hepatic microsomes that oxidize drugs. Biochem. Biophys. Res. Commun. 52: 588-594, 1973.
326. VATSIS, K. P., AND M. P. SCHULMAN. An unidentified constituent of ethanol oxidation in hepatic microsomes (Abstract). Federation Proc. 33: 554, 1974.
327. VAZ, A. D. N., E. S. ROBERTS, AND M. J. COON. Reductive β-scission of the hydroperoxides of fatty acids and xenobiotics: role of alcohol inducible cytochrome P-450. Proc. Natl. Acad. Sci. USA 87: 5499-5503, 1990.
328. WATANABE, J., S. HAYASHI, AND K. KAWAJIRI. Different regulations and expression of the human CYP2E1 gene due to the Rsa I polymorphism in the 5′ flanking region. J. Biochem. 116: 321-326, 1994.
329. WATANABE, K., S. NARIMATSU, I. YAMAMOTO, AND H. YOSHIMURA. Oxygenation mechanism in conversion of aldehyde to carboxylic acid catalyzed by a cytochrome P-450 isozyme. J. Biol. Chem. 226: 2709-2711, 1991.
330. WATANABE, J., J. P. YANG, H. EGUCHI, S. HAYASHI, K. IMAI, K. NAKACHI, AND K. KAWAJIRI. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn. J. Cancer Res. 86: 245-248, 1995.
331. WATKINS, J. B., R. A. SANDERS, AND G. A. BECK. The effect of long-term stretozotocin induced diabetes on the hepatotoxicity of bromobenzene and carbon tetrachloride and hepatic biotransformation in rats. Toxicol. Appl. Pharmacol. 93: 229-238, 1988.
332. WHEELER, C. W., S. A. WRIGHTON, AND T. M. GUENTHNER. Detection of human lung cytochromes P-450 that are immunochemically related to cytochrome P-450IIE1 and cytochrome P-450IIIA. Biochem. Pharmacol. 44: 183-186, 1992.
333. WICKRAMASINGHE, S. N., G. BARDEN, AND L. LEVY. The capacity of macrophages from different murine tissues to metabolize ethanol and generate an ethanol dependent nondialyzable cytotoxic activity in vitro. Alcohol Alcohol. 22: 31-39, 1987.
334. WILSON, R. H. L., E. J. NEWMAN, AND H. W. NEWMAN. Diurnal variation in rate of alcohol metabolism. Hepatology 6: 823-829, 1956.
335. WINTERS, D. K., L. A. CLEJAN, AND A. I. CEDERBAUM. Oxidation of glycerol to formaldehyde by rat liver microsomes. Biochem. Biophys. Res. Commun. 153: 612-617, 1988.
336. WRIGHTON, S. A., P. E. THOMAS, D. T. MOLOWA, M. HANIU, J. E. SHIVELY, S. L. MAINES, P. B. WATKINS, G. PARKER, G. MENDEZ-PICON, W. LEVIN, AND P. S. GUZELIAN. Characterization of ethanol inducible human liver N-mtrosodimethylamine demethylase. Biochemistry 25: 6731-6735, 1986.
337. WRIGHTON, S. A., P. E. THOMAS, D. E. RYAN, AND W. LEVIN. Purification and characterization of ethanol inducible human hepatic cytochrome P-450H1j. Arch. Biochem. Biophys. 258: 292-297, 1987.
338. WU, D., AND A. I. CEDERBAUM. Presence of functionally active cytochrome P-450IIE1 in the plasma membrane of rat hepatocytes. Hepatology 15: 515-524, 1992.
339. WU, D., AND A. I. CEDERBAUM. Induction of liver cytochrome P-4502E1 by pyrazole and 4-methylpyrazole in neonatal rats. J. Pharmacol. Exp. Ther. 264: 1468-1473, 1993.
340. WU, D., L. A. CLEJAN, B. POTTER, AND A. I. CEDERBAUM. Rapid decrease of cytochrome P-450IIE1 in primary hepatocyte culture and its maintenance by added 4-methylpyrazole. Hepatocyte 6: 1379-1389, 1990.
341. YAMAZAKI, H., Z. GUO, AND F. P. GUENGERICH. Selectivity of cytochrome P-4502E1 in chlorzoxazone 6-hydroxylation. Drug Metab. Dispos. 23: 438-440, 1995.
342. YANG, C. S., Y. Y. TU, D. R. KOOP, AND M. J. COON. Metabolism of nitrosamines by purified rabbit liver cytochrome P-450 isozymes. Cancer Res. 45: 1140-1145, 1985.
343. YANG, C. S., J.-S. YOO, H. ISHIZAKI, AND J. HONG. Cytochrome P-450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab. Rev. 22: 147-159, 1990.
344. YOO, J. H., J. Y. HONG, S. M. NING, AND C. S. YANG. Role of dietary corn oil in the regulation of cytochromes P-450 and glutathione S-transferases in rat liver. J. Nutr. 120: 1718-1726, 1990.
345. YOO, J. H., S. M. NING, C. B. PANTUCK, E. J. PANTUCK, AND C. S. YANG. Regulation of hepatic microsomal cytochrome P-450 IIE1 level by dietary lipids and carbohydrates in rats. J. Nutr. 121: 959-965, 1991.
346. YU, M.-W., A. GLADEK-YARBOROUGH, S. CHIAMPRASERT, R. M. SANTELLA, Y.-F. LIAW, AND C.-J. CHEN. Cytochrome P-450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109: 1266-1273, 1995.
347. YUN, Y.-P., J. P. CASAZZA, D. H. SOHN, R. L. VEECH, AND B. J. SONG. Pretranslational activation of cytochrome P-450IIE1 during ketosis induced by a high fat diet. Mol. Pharmacol. 41: 474-479, 1992.
348. ZAND, R., S. D. NELSON, J. T. SLATTERY, K. E. THUMMEL, T. F. KALHORN, S. P. ADAMS, AND J. M. WRIGHT. Inhibition and induction of cytochrome P-4502E1 catalyzed oxidation by isoniazid in humans. Clin. Pharmacol. Ther. 54: 142-149, 1993.
349. ZHANG, H., L. A. LONEY, AND B. J. POTTER. Effect of chronic alcohol feeding on hepatic iron status and ferritin uptake by rat hepatocytes. Alcohol. Clin. Exp. Res. 17: 394-400, 1993.
350. ZHANG, Z. Y., AND L. S. KAMINSKY. Characterization of human cytochromes P-450 involved in theophylline 8-hydroxylation. Biochem. Pharmacol. 50: 205-211, 1995.
351. ZIEGLER, D. M. Discussion in microsomes and drug oxidation. In: Microsomes and Drug Oxidations, edited by R. W. Estabrook, R. J. Gillette, and K. C. Liebman. Baltimore, MD: Williams & Wilkins, 1972, p. 458.